Stock Market Opportunities as COVID Worsens
As an active trader and market participant, you’ve definitely taken notice of how the markets have been behaving over the last couple of weeks… the bull markets this summer have taken slight pause and you maybe stressing that it might be the end of the story…
The COVID virus has got worse again. Countries all over the world are increasing restrictions and even going into lockdown again…
But, you don’t need to fear or own a crystal ball to see opportunities now in the stock market. What you have to be doing is interacting intelligently with the news and the market action thats unfolding in real time.
The vaccine stocks have been selling off for the last few weeks, yes… but the good news is: it seems like their prices have hit a bottom and could be a leading indicator that the tech stock could rebound and go higher.
Watch the full interview to see which stocks are leading this charge.
Speaking of stocks leading the way during the COVID pandemic…
I’ve been tracking the changes in markets since the virus started forcing economies to change . My newsletter portfolio is currently up over 175% since March. That’s 96.42% higher than the S&P 500 in the same period of time.
On Wednesday September 23, I am revealing exactly my thought process that has allowed my members to enjoy those kinds of stock gains… LIVE and FOR FREE.
That’s right – click here and scroll to the bottom of the page to enter your email to reserve your spot for this special presentation.
I would love to see you there!
Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.
Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.
Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.